Natriuretic peptides in heart failure.
Clinical Chemistry Fellow, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;
Danny C C
DC
Lin
Professor and Head, Division of Clinical Biochemistry, Department of Laboratory Medicine and Pathobiology, University of Toronto; Head of Clinical Biochemistry, Department of Clinical Biochemistry, University Health Network; Head of Clinical Biochemistry, Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; ediamandis@mtsinai.on.ca.
Eleftherios P
EP
Diamandis
Roman W. Desanctis Endowed Distinguished Clinical Scholar and Director, Coronary Care Unit, Massachusetts General Hospital; Professor of Medicine, Harvard Medical School, Boston, MA;
James L
JL
Januzzi
Professor of Medicine at the University of California, San Diego (UCSD); Director, Coronary Care Unit and Heart Failure Program, Veterans Affairs San Diego Medical Center, UCSD, San Diego, CA;
Alan
A
Maisel
Professor of Medicine, Consultant, Division of Cardiovascular Diseases, and Director, Clinical Core Laboratory Services, Mayo Clinic, Rochester, MN;
Allan S
AS
Jaffe
Laboratory of Cardiovascular Endocrinology and Cell Biology, Fondazione CNR-Toscana G. Monasterio, Scuola Superiore Sant'Anna, Pisa, Italy.
Aldo
A
Clerico
D015415:Biomarkers / Q000097:blood*; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000737:chemistry
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain